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Fernandes et al estimated a dengue prevalence of 2.64% in KT recipients from a 5-year retrospective study from a single transplant center in Brazil. 3 Furthermore, most studies classified dengue infection according to a 1997 World Health Organization (WHO) classification system that did not consider the more specific pathophysiology of plasma leakage compared with a newer 2009 WHO classification system. Despite recent advances in molecular testing, reverse transcription-polymerase chain reaction (RT-PCR) for dengue diagnosis in KT recipients has not been utilized. Herein, we performed a 20-year retrospective study to investigate the epidemiology and outcomes from dengue in KT recipients at our transplant center, and we reviewed all known studies of dengue in KT recipients published within the last decade. 
| MATERIAL S AND ME THODS

| RE SULTS
| Epidemiology and demographic data
Clinical characteristics of KT recipients with dengue are shown in 
| Dengue diagnosis
| Management and outcomes
All patients' outcomes are shown in Table 3 . All patients were admitted to the hospital, and two were admitted to the intensive care unit (ICU). The median length of admission was 6 days (IQR:
4-10 days). All patients were admitted into the hospital for supportive treatment including closely vital sign measurement and fluid replacement. They also underwent an optimization of immunosuppression including discontinuation of mycophenolate mofetil in all patients then later gradually resume after clinical resolution except one patient was later switched to azathioprine. Tacrolimus and cyclosporine were kept at trough levels of <6 and 150 ng/ mL, respectively. Tacrolimus was switched to cyclosporine in one patient. Prednisolone was kept as low as tolerated of 5-10 mg/ day. The majority of cases completely resolved without complications, and no deaths were observed. Two patients developed a 
| Comparative literature review
We conducted a comparative review that included six retrospective studies and this study. [2] [3] [4] [5] [6] [7] Clinical characteristics, laboratory findings, and treatment outcomes for all KT recipients are presented in Table 4 .
All studies were published between 2007 and 2018, with the majority being from South Asia, particularly India and Pakistan. 3, [5] [6] [7] Two reports were from Brazil. 2, 4 Three studies were outbreak investigations (2010, 2015, and 2017). 3, 5, 6 Those with prevalence data reported values ranging from 0.7% to 2.6%; one outbreak produced a 39.5%
prevalence. The majority of cases were males in their 30s and 40s.
Fever was the most common initial presentation, occurring in nearly 100% of cases in each cohort, followed by myalgia and headache. A few patients reported gastrointestinal symptoms, arthralgia, or clinical bleeding. Pleural effusion was reported 8%-15% of the time, except for one cohort in an outbreak setting that reported up to 88% pleural effusion prevalence. Serology was primarily used for dengue diagnosis, followed by NS1 antigen, and RT-PCR was used in only two studies. The rates of leukopenia, thrombocytopenia, and transaminitis were similar across each cohort. The majority of cases were admitted to the hospital with transient allograft dysfunction, and their creatinine was elevated within the range of 1.7-2.5 mg/dL above baseline.
Allograft failure was reported in 8%-15% of cases. The mortality rate was <10%, except for the 38% mortality rate in an outbreak setting.
| D ISCUSS I ON
Herein, we analyzed recent comprehensive data on the epidemiology, clinical characteristics, laboratory findings, and treatment outcomes of dengue in KT recipients in the largest retrospective cohort from an endemic area. We found that dengue in KT patients is relatively uncommon and has an overall favorable clinical outcome with a transient decline in allograft function that was comparable to other findings in the literature. Herein, we also report on a potentially prolonged dengue RNAemia and a complication with HLH in KT recipients.
A dengue epidemic among solid organ transplant (SOT) recipients was reported from an endemic area, 11 wherein KT recipients were the main focus of the study. Additionally, there are six cohort studies in the literature, including three that catalogue outbreaks. [3] [4] [5] [6] [7] [8] All existing studies come from endemic areas including South America, South Asia, and Southeast Asia (our study). The prevalence of dengue in KT recipients ranged from <1% to 3%. With a long follow-up period in our study, we found that dengue was relatively uncommon in this immunocompromised population. The prevalence estimate from our study was relatively low compared with Fernandes et al's estimates, which come from an outbreak context. 3, 7 Dengue among immunocompetent patients in Thailand had an incidence of approximately 100 cases/100 000 population/year, which is considered to be a hyperendemic situation. 12 This lower value could be due to the we found severe dengue in one out of every six infected patients. A systematic review reported a significantly higher incidence of severe dengue among KT recipients. 9 To compare with previously studied cohorts, we also defined dengue according to the WHO 1997 classification system, which yielded 5 (38.5%) classic dengue and 7
TA B L E 3 Outcome of 13 kidney transplant recipients with dengue
(53.8%) dengue hemorrhagic fever (DHF) cases. We found a relatively higher number of DHF cases compared with other cohorts, with the exception of the outbreak setting. 6, 8 The majority of the studies utilized dengue serology for diagnosis, but the relatively low sensitivity and specificity of dengue serology is a concern. Recent studies used were similar to those of immunocompetent patients. Pleural effusion was uncommon in our cohort; however, it was relatively common in an outbreak study where it contributed to high mortality. 6, 8 All patients in our study had favorable outcomes without significant morbidities. This could be because they received early diagnoses, timely supportive treatment, and reduced immunosuppressants. All patients were admitted to the hospital, including two to the ICU. The typical admission duration for our cohort was approximately 1 week, but was sometimes as long as 10 days, which was similar to that in Fernandes et al's study. In the case-control study in the outbreak setting, KT recipients had lower WBC counts and longer platelet count recoveries compared with immunocompetent and CKD patients. 4 No patients died in our cohort, which contrasts with the other studies we reviewed, where mortality ranged from relatively low to high (38%) in the outbreak setting. One patient in our study developed HLH, but eventually had a full recovery after receiving IVIG. Dengue-associated HLH is uncommon and is associated with high mortality. 15, 16 Although HLH has been reported in previous studies, it had never been reported in a KT patient. There was no opportunistic infection other than dengue in our cohort. Invasive aspergillosis following severe dengue has been reported in an autopsy series. 17 However severe dengue could possibly be one of the mechanism, though the empirical evidence for this pathway has not been confirmed. [18] [19] [20] Although patients can develop allograft dysfunction from multifactorial causes, there is no direct evidence of its association with dengue. A possible allograft rejection could occur if immunosuppressant therapy is reduced during active infection. KT recipients may have lower requirements for hemodialysis compared with CKD patients, which could be important in an outbreak setting. 4 Although a previous systematic review reported a possible higher mortality associated with severe dengue, only a few patients developed graft failure, and those failures were not related to dengue infection. 
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